Latest Investments News

Brightstar Resources has received court approval to acquire Aurumin Limited, consolidating the Sandstone Gold Project and boosting its combined mineral resource to 2.4 million ounces. The acquisition positions Brightstar as a rising mid-tier gold producer in Western Australia.

Catalina Resources is set to commence a major 20,000-metre drilling program across its Evanston and Yerilgee gold projects in December 2025, targeting high-grade gold zones in underexplored Western Australian greenstone belts.

Cash Converters has completed a $25 million equity raise to fund the acquisition of 29 Australian franchise stores, with EZCORP increasing its voting power to nearly 44%.

Meeka Metals has reported significant shallow high-grade gold intercepts at its Andy Well underground mine, extending the Wilber lode strike by approximately 450 metres south and highlighting potential for resource growth within 200 metres depth.

Australian Agricultural Company Limited (AACo) reported a record first-half operating profit of $39.8 million, boosted by higher beef and cattle prices and volumes, alongside strategic investments in feedlot expansion and carbon projects.

Australian Agricultural Company Limited (AACo) has reported a record first-half operating profit of $39.8 million, nearly doubling from the previous year, driven by higher beef prices and strategic live cattle sales. The company’s investments in genetics, carbon projects, and global market expansion set a strong foundation for future growth.

Australian Agricultural Company Limited (AACo) has reported robust growth in its FY26 half-year results, with significant increases in operating profit, statutory EBITDA, and cattle sales driving the upbeat performance.

TPG Telecom has launched a $138 million Retail Reinvestment Plan, allowing eligible shareholders to reinvest proceeds from a $3 billion capital return. This initiative complements a $300 million institutional plan, aiming to reduce debt and enhance shareholder value.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.

The a2 Milk Company has raised its FY26 revenue guidance, citing stronger-than-expected performance in key product categories and favourable currency movements. The company anticipates solid earnings growth and robust cash flow conversion.